scholarly journals Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers

2003 ◽  
Vol 52 (4) ◽  
pp. 719-723 ◽  
Author(s):  
M. van Boven
2012 ◽  
Vol 18 (1) ◽  
pp. 19-22
Author(s):  
Mounira Smati ◽  
Jean-Philippe Emond ◽  
Guillaume Arlet ◽  
Jacques Tankovic

1999 ◽  
Vol 43 (10) ◽  
pp. 2493-2496 ◽  
Author(s):  
George E. Kenny ◽  
Patrick A. Young ◽  
Frank D. Cartwright ◽  
Karen E. Sjöström ◽  
Wai M. Huang

ABSTRACT The role of mutations in the genes for GyrA and ParC in quinolone resistance in Mycoplasma hominis was studied. Selection with sparfloxacin gave mutations at GyrA83 (Ser→Leu;Escherichia coli numbering) or GyrA87 (Glu→Lys), and mutants had increased levels of resistance to sparfloxacin (8- to 16-fold) but not to ofloxacin. Selection with ofloxacin gave changes at ParC80 (Ser→Ile) or ParC84 (Glu→Lys), and mutants were four- to eightfold more resistant to ofloxacin but not to sparfloxacin. Selection of second-step mutants from strains with ParC mutations with either quinolone yielded double mutants with additional mutations at GyrA83 (Ser→Trp or Ser→Leu) or GyrA87 (Glu→Lys). Second-step selection of GyrA mutants gave additional mutations at ParC80 (Ser→Ile) or ParC84 (Glu→Lys). Two-step mutants showed high levels of resistance to ofloxacin (MICs, 64 to 128 μg/ml) and moderate levels of resistance to sparfloxacin (MICs, 2 to 8 μg/ml). The primary target of ofloxacin in first-step mutants of Mycoplasma hominis was ParC, whereas that for sparfloxacin was GyrA.


2006 ◽  
Vol 50 (4) ◽  
pp. 1525-1527 ◽  
Author(s):  
Laurent Poirel ◽  
Johann D. D. Pitout ◽  
Lucy Calvo ◽  
Jose-Manuel Rodriguez-Martinez ◽  
Deirdre Church ◽  
...  

ABSTRACT A ciprofloxacin-resistant Escherichia coli isolate, isolate 1B, was obtained from a urinary specimen of a Canadian patient treated with norfloxacin for infection due to a ciprofloxacin-susceptible isolate, isolate 1A. Both isolates harbored a plasmid-encoded sul1-type integron with qnrA1 and bla VEB-1 genes. Isolate 1B had amino acid substitutions in gyrase and topoisomerase.


2015 ◽  
Vol 37 (1se) ◽  
Author(s):  
Nguyen Thi Quy ◽  
Duong Thu Huong ◽  
Dang Thi Ngoc Ha ◽  
Le Thi Thu Hong ◽  
Do Thi Huyen ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0218134 ◽  
Author(s):  
Koen B. Pouwels ◽  
Berit Muller-Pebody ◽  
Timo Smieszek ◽  
Susan Hopkins ◽  
Julie V. Robotham

2021 ◽  
Vol 9 (3) ◽  
pp. 503
Author(s):  
Michael Bording-Jorgensen ◽  
Hannah Tyrrell ◽  
Colin Lloyd ◽  
Linda Chui

Acute gastroenteritis caused by Shiga toxin-producing Escherichia coli (STEC) affects more than 4 million individuals in Canada. Diagnostic laboratories are shifting towards culture-independent diagnostic testing; however, recovery of STEC remains an important aspect of surveillance programs. The objective of this study was to compare common broth media used for the enrichment of STEC. Clinical isolates including O157:H7 as well as non-O157 serotypes were cultured in tryptic soy (TSB), MacConkey (Mac), and Gram-negative (GN) broths and growth was compared using culture on sheep’s blood agar and real-time PCR (qPCR). In addition, a selection of the same isolates was spiked into negative stool and enriched in the same three broths, which were then evaluated using culture on CHROMagarTM STEC agar and qPCR. TSB was found to provide the optimal enrichment for growth of isolates with and without stool. The results from this study suggest that diagnostic laboratories may benefit from enriching STEC samples in TSB as a first line enrichment instead of GN or Mac.


1993 ◽  
Vol 39 (2) ◽  
pp. 155-158 ◽  
Author(s):  
P. M. Zadik ◽  
P. A. Chapman ◽  
C. A. Siddons

Sign in / Sign up

Export Citation Format

Share Document